Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists

Download All
This activity will improve the knowledge and competence of pharmacists about the management of anticoagulant-related bleeding, including recent guideline updates, selecting appropriate reversal agents and dosing strategies, clinical data regarding the efficacy and safety outcomes of reversal agents for oral anticoagulants, and strategies to address formulary concerns, including access to reversal agents, streamlining administration, waste prevention, and institutional policy development to improve patient care.
Tyree H. Kiser, PharmD, FCCP, FCCM, BCCCP, BCPS
person default
Charles “Kurt” Mahan, PharmD, PhC, FASHP, FCCP

ClinicalThought

Expert faculty answer the most compelling questions from the live ProCE symposium, “Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists”

Tyree H. Kiser, PharmD, FCCP, FCCM, BCCCP, BCPS Released: December 30, 2021

What do the data tell us about DOAC reversal as a strategy for controlling major bleeding? Have we been using agents in strategies unsupported by data?

person default Charles “Kurt” Mahan, PharmD, PhC, FASHP, FCCP Released: January 5, 2022
Provided by ProCE, LLC, a Clinical Education Alliance Company

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an educational grant from
Alexion
AstraZeneca Rare Disease

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings